We also develop clinical tests to help healthcare providers assess patients’ cardiovascular disease risk and determine the most effective treatment strategy. Our B·R·A·H·M·S Copeptin proAVP KRYPTOR enables hospital emergency departments to quickly determine whether a patient is experiencing a heart attack to ensure they receive the proper care. And we also offer assays that detect high-density lipoprotein cholesterol (HDL-C), an indicator of increased risk of cardiovascular disease, to enable timely intervention and improved outcomes.
Let’s beat cardiovascular disease together. By making heart-healthy choices, you can significantly reduce your risk of cardiovascular disease. And Thermo Fisher will continue to put its heart into enabling our customers to combat this global health challenge.